Moonshot. Long shot. Or sure shot. What needs to happen to realize the full potential of AI in the fertility sector?
View abstract on PubMed
Summary
This summary is machine-generated.Artificial intelligence (AI) in fertility care offers significant potential but requires careful implementation. A strategic roadmap is essential for integrating AI into assisted reproductive technology (ART) to ensure patient benefit and safe adoption.
Area Of Science
- Reproductive medicine
- Health technology assessment
- Clinical decision support systems
Background
- Healthcare decision-making is shifting from opinion-based to evidence-based and data-driven processes.
- Artificial intelligence (AI) is increasingly recognized for its potential value in clinical settings.
- The fertility sector is actively debating the integration of AI into reproductive technologies.
Purpose Of The Study
- To discuss critical factors for the successful implementation of AI in fertility care.
- To outline a roadmap for transitioning from provider-driven decisions to software-enhanced systems.
- To explore how AI can improve workflow, outcomes, and performance in assisted reproductive technology (ART).
Main Methods
- This opinion piece reviews the current landscape of AI in fertility.
- It identifies key areas for consideration in technology adoption.
- The discussion focuses on strategic implementation rather than empirical data collection.
Main Results
- Widespread adoption of AI in fertility is urged, but caution is advised based on experiences in other clinical fields.
- The potential benefits of AI in fertility care are substantial and engaging.
- Thoughtful implementation strategies are crucial for realizing AI's potential.
Conclusions
- Successful AI uptake in fertility requires addressing the value proposition, innovative disruption, clinical agency, and responsible computing.
- A strategic approach is needed to navigate the integration of AI into ART.
- Careful planning will enhance the safe and effective use of AI to improve fertility treatments.
Related Concept Videos
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
The first successfully cloned mammal was Dolly, a sheep, born on 5th July 1996 at Roslin Institute, Scotland. The cloned sheep was named after the American singer Dolly Parton. Dolly lived for seven years and died of respiratory complications, which is speculated to be due to the actual age of her DNA. Because the DNA in cloned cells belongs to an older individual, the cloned individual’s life expectancy may be affected. Indeed, analysis of Dolly’s DNA revealed shorter...

